We are an international
independent scientific network

devoted to advancing research on optimising the prevention,
diagnosis and treatment of infectious diseases in children globally

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

Sharing values and goals

such as flexibility, commitment and transparency

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

Understanding the
immune response

so as to harness the body's response
to HIV and antiretrovirals

antimicrobial resistance

to ensure effective treatments are available
for common infections for generations to come

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

Get to know us

Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Current Penta studies around the World

Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.





Years of activity


Ongoing studies and projects

Latest News

SUPPORT project launches to equip the next generation of African experts to fight childhood HIV 

11 Jul, 2024

A new collaborative project called SUPPORT has officially launched to train the next generation of researchers who will focus on preventing mortality among these children. The SUPPORT initiative, funded by…
Read More

PentaTr@ining Oman 2024: Working together to tackle vertical transmission of HIV, syphilis, and hepatitis B in maternal and child health

28 Jun, 2024

From 14 to 16 May, 2024, PentaTr@ining in collaboration with UNICEF, the World Health Organization (WHO) and with support from the International Organization for Migration (IOM), brought together over 50…
Read More

Significant advancements and fifteen month extension for the RBDCOV project

25 Jun, 2024

The European Commission has granted a 15-month extension to the RBDCOV project, allowing researchers additional time to recruit volunteers for the HH-3 clinical trial. This trial assesses the efficacy, tolerability,…
Read More

VERDI General Assembly 2024: Sustainability and Future Directions

24 Jun, 2024

Last week, the VERDI project team gathered in Tallinn, Estonia, and online for the 4th General Assembly. This year’s meeting, which brought together around 60 people from 30 partner institutions,…
Read More

VERDI poster wins “Best Poster” Award at ESPID 2024!

12 Jun, 2024

We are pleased to announce that the poster “SARS-CoV-2 Infection Incidence and Severity in Immunocompromised Children: A Population-Based Study in Italy and Norway” has received the Best Poster Award from the ESPID Committee for…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people